1.Palmer, RM. Acute care of the elderly: minimizing the risk of functional decline. Cleve Clin J Med 1995;62:117–128.
2.Medina-Walpole, AM, Katz, PR. Nursing home-acquired pneumonia. J Am Geriatr Soc 1999;47:1005–1015.
3.Loeb, M, McGeer, A, McArthur, M, Walter, S, Simor, AS. Risk factors for pneumonia and other lower respiratory tract infections in elderly residents of long-term care facilities. Arch Intern Med 1999;159:2058–2064.
4.Muder, RR. Pneumonia in residents of long-term care facilities: epidemiology, etiology, management and prevention. Am J Med 1998;105:319–330.
5.Bentley, DW. Bacterial pneumonia in the elderly: clinical features, diagnosis, etiology and treatment. Gerontology 1984;30:297–307.
6.Garibaldi, RA, Brodine, S, Masumiya, S. Infections among patients in nursing homes: policies, prevention and problems. N Engl J Med 1981; 305:731–735.
7.Marrie, TJ. Epidemiology of community-acquired pneumonia in the elderly. Semin Respir Infect 1990;5:260–268.
8.Metlay, JP, Schulz, R, Li, Y-H, et al. Influence of age on symptoms at presentation on patients with community-acquired pneumonia. Arch Intern Med 1997;157:1453–1459.
9.Wipf, JE, Lipsky, BA, Hirschman, JV, et al. Diagnosing pneumonia by physical examination: relevant or relic. Arch Intern Med 1999;159:1082–1087.
10.Marrie, TJ, Blanchard, W. A comparison of nursing home-acquired pneumonia patients with patients with community-acquired pneumonia and nursing home patients without pneumonia. J Am Geriatr Soc 1997;45:50–55.
11.El-Solh, AA, Sikka, P, Ramadan, F, Davies, J. Etiology of severe pneumonia in the very elderly. Am J Respir Crit Care Med 2001;163:645–651.
12.Patriarca, PA, Weber, JA, Parker, SAet al. Risk factors for outbreaks of influenza in nursing homes. Am J Epidemiol 1986;124:114–119.
13.Sorvillo, FJ, Huie, SF, Strassburg, MA, Butsumyo, A, Shandera, WX, Fannin, SL. An outbreak of respiratory syncytial virus pneumonia in a nursing home for the elderly. J Infect 1984;9:252–256.
14.Kludt, P, Lett, SM, De Maria, A, et al. Outbreaks of pneumococcal pneumonia among unvaccinated residents in chronic care facilities— Massachusetts, October 1995, Oklahoma, February 1996, and Maryland, May-June 1996. MMWR 1997;46:60–62.
15.Troy, CJ, Peeling, RW, Ellis, AG, et al. Chlamydia pneumoniae as a new source of infectious outbreaks in nursing homes. JAMA 1997;277:1214–1218.
16.Loeb, M, Simor, AE, Mandell, L, et al. Two nursing home outbreaks of respiratory infection with Legionella sainthelensi. J Am Geriatr Soc 1999; 47:547–552.
17.Kotilaninen, P, Routamaa, M, Peltonen, Ret al. Eradication of methicillin-resistant Staphylococcus aureus from a health center ward and associated nursing home. Arch Intern Med 2001;161:859–863.
18.Terpenning, MS, Bradley, SF, Wan, JY, Chenoweth, CE, Jorgensen, KA, Kauffman, CA. Colonization and infection with antibiotic resistant bacteria in a long term care facility. J Am Geriatr Soc 1994;42:1062–1069.
19.Flournoy, DJ. Antimicrobial susceptibilities of bacteria from nursing home residents in Oklahoma. Gerontology 1994;40:53–56.
20.Marrie, TJ, Durant, H, Yates, L. Community-acquired pneumonia requiring hospitalization: 5-year prospective study. Rev Infect Dis 1989;11:586–599.
21.Garb, JL, Brown, RB, Garb, JR, Tuthill, RW. Differences in etiology of pneumonias in nursing home and community patients. JAMA 1978;240:2169–2172.
22.Orr, PH, Peeling, RW, Fast, M, et al. Serological study of responses to selected pathogens causing respiratory tract infection in the institutionalized elderly. Clin Infect Dis 1996;23:1240–1245.
23.Phillips, SL, Branaman-Phillips, J. The use of intramuscular cefoperazone versus intramuscular ceftriaxone in patients with nursing home acquired pneumonia. J Am Geriatr Soc 1993;41:1071–1074.
24.Drinka, PJ, Gauerke, C, Voeks, S, et al. Pneumonia in a nursing home. J Gen Intern Med 1994;9:650–652.
25.Chow, CW, Senathiragah, N, Rawji, M, et al. 1994 interim report on drug utilization review of community-acquired and nosocomial pneumonia: clinical bacteriological and radiological spectrum. Can J Infect Dis 1994;5(suppl C):20C–27C.
26.Bentley, DW, Bradley, S, High, K, Schoenbaum, S, Taler, G, Yoshikawa, T. Practice guidelines for evaluation of fever and infection in long-term-care-facilities. Clin Infect Dis 2000;31:640–653.
27.Degelau, J, Guay, D, Straub, K, Luxenberg, MG. Effectiveness of oral antibiotic treatment in nursing home acquired pneumonia. J Am Geriatr Soc 1995;43:245–251.
28.Naughton, BJ, Mylotte, JM. Treatment guideline for nursing home-acquired pneumonia based on community practice. J Am Geriatr Soc 2000;48:82–88.
29.Intrator, O, Castle, NG, Mor, V. Facility characteristics associated with hospitalization of nursing home residents: results of a national study. Med Care 1999;37:228–237.
30.Naughton, BJ, Mylotte, JM, Tayara, A. Outcome of nursing home-acquired pneumonia: derivation and application of a practical model to predict 30 day mortality. J Am Geriatr Soc 2000;48:1292–1299.
31.Meehan, TP, Fine, MJ, Krumholz, HM, et al. Quality of care, process and outcomes in elderly patients with pneumonia. JAMA 1997;278:2080.
32.Gleason, PP, Meehan, TP, Fine, JM, Galusha, DH, Fine, MJ. Associations between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia. Arch Intern Med 1999;159:2562–2572.
33.Nicolle, LE, Kirshen, A, Boustcha, E, Montgomery, P. Treatment of moderate-to-severe pneumonia in elderly, long-term care facility residents. Infectious Diseases in Clinical Practice 1996;5:130–137.
34.Peterson, PK, Stein, D, Guay, DRP, et al. Prospective study of lower respiratory tract infections in an extended-care nursing home program: potential role of oral ciprofloxacin. Am J Med 1988;85:164–171.
35.Hirta-Dulas, CAI, Stein, DJ, Guay, DRP, et al. A randomized study of ciprofloxacin versus ceftriaxone in the treatment of nursing home-acquired lower respiratory tract infections. J Am Geriatr Soc 1991; 39:979–985.
36.Phillips, SL, Branaman-Phillips, J. The use of intramuscular cefoperazone versus intramuscular ceftriaxone in patients with nursing home-acquired pneumonia. J Am Geriatr Soc 1993;41:1071–1074.
37.Mandell, IA, Marrie, TJ, Grossman, RF, Chow, AW, Hyland, RH, and the Canadian Community-Acquired Pneumonia Working Group. Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. Clin Infect Dis 2000;31:383–421.
38.Bartlett, JG, Dowell, SF, Mandell, LAFile, TM Jr, Musher, DM, Fine, MJ. Practice guidelines for the management of community-acquired pneumonia in adults. Clin Infect Dis 2000;31:347–382.
39.Nicolle, LE, Bentley, DW, Garibaldi, R, Neuhaus, EG, Smith, PW, the SHEA Long-Term-Care Committee. Antimicrobial use in long-term–care facilities. Infect Control Hosp Epidemiol 2000;21:537–545.
40.Gross, PA, Hermogenes, AW, Sacks, HS, Lau, J, Levandowski, RA. The efficacy of influenza vaccine in elderly persons: a meta-analysis and review of the literature. Ann Intern Med 1995;123:518–527.
41.Nichol, KL, Margolis, KL, Wuorenma, J, Von Sternberg, T. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med 1994;31:778–784.
42.Treanor, JJ, Mattison, HR, Dumyati, G, et al. Protective efficacy of combined live intranasal and inactivated influenza A virus vaccines in the elderly. Ann Intern Med 1992;117:625–633.
43.Potter, J, Stott, DJ, Roberts, MA, et al. Influenza vaccination of health care workers in long-term-care hospitals reduces the mortality of elderly patients. J Infect Dis 1997;175:1–6.
44.Fine, MJ, Smith, MA, Carson, CA, et al. Efficacy of pneumococcal vaccination in adults: a meta-analysis of randomized controlled clinical trials. Arch Intern Med 1994;154:2666–2677.
45.Ortqvist, A, Hedlund, J, Burman, L-A, et al. Randomised trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people. Lancet 1998;351:399–403.
46.Koivula, I, Sten, M, Leinonen, M, Makela, PH. Clinical efficacy of pneumococcal vaccine in the elderly: a randomized, single-blind population-based trial. Am J Med 1997;103:281–290.
47.Nichol, KL, Baken, L, Wuorenma, J, Nelson, A. The health and economic benefits associated with pneumococcal vaccination of elderly people with chronic lung disease. Arch Intern Med 1999;159:2437–2442.
48.Mbelle, N, Wasas, A, Huebner, R, Kimura, A, Chang, I, Klugman, K. Immunogenicity and impact on carriage of 9-valent pneumococcal conjugate vaccine given to infants in Soweto, South Africa. Proceedings of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. Herndon, VA: ASM Press; 1997.
49.Gesner, M, Desidero, D, Kim, M, et al. Streptococcus pneumoniae in human immunodeficiency virus type 1 infected children. Pediatr Infect Dis J 1994;13:697–703.
50.Buikema, AR, Singelton, JA, Sneller, VP, Strikas, RA. Influenza and pneumococcal vaccination in nursing homes, U.S. 1995-1999. Presented at the 35th National Immunization Conference; 2001; Atlanta, GA. Abstract.
51.Morton, MR, Spruill, WJ, Cooper, JW. Pharmacist impact on pneumococcal vaccination rates in long-term care facilities. American Journal of Hospital Pharmacy 1998;45:73. Letter.
52.Stevenson, KB, McMahon, JW, Harris, J, Hillman, JR, Helgerson, SD. Increasing pneumococcal vaccination rates among residents of long-term-care facilities: provider-based improvement strategies implemented by peer-review organization in four western states. Infect Control Hosp Epidemiol 2000;21:705–710.